Sandoz

Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Pharma

Sandoz inks dual settlements to resolve most US antitrust claims

Novartis’ generics and biosimilars spinout Sandoz is plotting its escape from ongoing U.S. litigation tied to alleged generic drug price-fixing.

Fraiser Kansteiner Aug 3, 2026 10:18am

Evolution step-up growth trajectory upward trajectory

How biosimilar developers are embracing next phase of US market

Jul 6, 2026 10:03am

Asia

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

Mar 20, 2026 8:00am

NuProbe

Sandoz expands biosimilar collaboration with Samsung Bioepis

Mar 18, 2026 11:05am

Novartis Sandoz

Sandoz to break its biosimilars business out from generics

Mar 10, 2026 4:01pm

light gold

Biosimilar execs optimistic about future for US biosims

Jan 22, 2026 12:56pm